Literature DB >> 1766023

Six years of occult blood screening in an urban public hospital: concepts, methods, and reflections on approaches to reducing avoidable mortality among black Americans.

A Hoffman1, H Abcarian.   

Abstract

While early cancer detection is frequently overused in high socioeconomic status communities, opportunities for early detection often are overlooked by practitioners serving lower income and minority populations. Review of our patient records in 1980 revealed that only 13% of patients had a record of a rectal examination, and less than 1% had either proctoscopy or fecal occult blood testing. Our program has made a dramatic impact on colorectal cancer detection, performing 8192 fecal occult blood tests in the first 5 1/2 years of our program. As with other programs, stage of cancer is greatly influenced by fecal occult blood testing, with 0 modified Dukes' stage D compared to 33% for the hospital registry, and 35% stage A compared to 0 for the registry. Compliance with diagnostic evaluation has been excellent (89.6%). The program has allowed for increased communication between patients and staff. Education about diet and other prevention has been institutionalized. Patients see our nurses as their advocates and openly express their fears and concerns about their health and health care. We began our fecal occult blood testing program at a time when it was considered the "standard of care" although randomized clinical trial proof was, and is, incomplete. This program provides evidence that "standard of care" is feasible in the public sector.

Entities:  

Mesh:

Year:  1991        PMID: 1766023      PMCID: PMC2571616     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  Early detection of bowel cancer at an urban public hospital: demonstration project.

Authors:  A Hoffman; Q Young; P Bright-Asare; H Abcarian; J Fitzpatrick; E Lidow; M Farber; J Summerville; C Petani; C Orsay
Journal:  CA Cancer J Clin       Date:  1983 Nov-Dec       Impact factor: 508.702

2.  Current status of fecal occult blood testing in screening for colorectal cancer.

Authors:  S J Winawer; M Fleisher; M Baldwin; P Sherlock
Journal:  CA Cancer J Clin       Date:  1982 Mar-Apr       Impact factor: 508.702

3.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

  3 in total
  4 in total

1.  Colorectal screening patterns and perceptions of risk among African-American users of a community health center.

Authors:  I M Lipkus; B K Rimer; P R Lyna; A A Pradhan; M Conaway; C T Woods-Powell
Journal:  J Community Health       Date:  1996-12

2.  The impact of health insurance on an African-American population with colorectal cancer.

Authors:  F W Dawkins; A E Laing; D T Smoot; E Perlin; W B Tuckson
Journal:  J Natl Med Assoc       Date:  1995-04       Impact factor: 1.798

3.  Demographic differences in African-American patients with neoplastic lesions detected by flexible sigmoidoscopy.

Authors:  W McBride; G C Richter; K Frontin; J Sung
Journal:  J Natl Med Assoc       Date:  1995-12       Impact factor: 1.798

Review 4.  Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review.

Authors:  Keith Naylor; James Ward; Blase N Polite
Journal:  J Gen Intern Med       Date:  2012-08       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.